Chin-chung Wu
Professor
Translational Medicine
Kaohsiung Medical University
Taiwan
Biography
Chin-Chung Wu has received his PhD in in Pharmacology, National Taiwan University and is working as Professor in department of Translational Medicine, Kaohsiung Medical University. Research includes Cardiovascular Pharmacology, Cancer Pharmacology, Signal Transduction.
Research Interest
Cardiovascular Pharmacology, Cancer Pharmacology, Signal Transduction
Publications
-
Wang HC, Chang FR, Huang TJ, Kuo CY, Tsai YC, Wu CC. (−)-Liriopein B Suppresses Breast Cancer Progression via Inhibition of Multiple Kinases. Chemical research in toxicology. 2015 Apr 21;28(5):897-906.
-
Wang HC, Tsai YL, Wu YC, Chang FR, Liu MH, Chen WY, Wu CC. Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90. PloS one. 2012 May 31;7(5):e37764.
-
Wu CC, Wu SY, Liao CY, Teng CM, Wu YC, Kuo SC. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3â€kinase pathway in maintaining thrombinâ€induced platelet aggregation. British journal of pharmacology. 2010 Oct 1;161(3):643-58.
-
Wu CC, Wu CI, Wang WY, Wu YC. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins. Planta medica. 2007 Oct;53(05):439-43.
